Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of CR845 in Hemodialysis Patients with Uremic Pruritus
NCT02229929Phase 2Completed
- Sponsor
- Cara Therapeutics, Inc.
- Start
- Jul 2014
- Primary completion
- Jul 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of difelikefalin in uremic pruritus, sponsored by Cara Therapeutics, Inc.. Started Jul 2014; status: completed.
02
Drugs
difelikefalin
03
Conditions
uremic pruritus
Beyond the preview
Go deeper on NCT02229929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02229929.